Key Takeaways McKesson posted strong Q2 results with $103B revenues up 10% YoY and adjusted EPS jumping 39%.McKesson's Oncology and Multispecialty segment drove results, with revenues up 32% and profit up 71%.McKesson raised full-year EPS guidance to $38.35-$38.85 as automation drove major cost leverage.McKesson Corporation (MCK) has delivered a strong fiscal second quarter, reinforcing confidence in management’s full-year outlook and longer-term strategic repositioning. The company reported consolidated re ...